Coupon
The Promise of Low Dose Naltrexone Therapy : Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
by Elaine A. Moore and Samantha Wilkinson and Ph.D. M.D. Yash Pal Agrawal


Overview - Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS).  Read more...

 
Paperback
  • $25.00

Add to Cart + Add to Wishlist

In Stock Online.

Free Shipping is not available for this item.
 
> Check In-Store Availability

In-Store pricing may vary

 
 
New & Used Marketplace 2 copies from $17.71
 
eBook
Retail Price: $19.99
$15.14

Add to Cart + Add to Wishlist

Download

 
 
 

More About The Promise of Low Dose Naltrexone Therapy by Elaine A. Moore; Samantha Wilkinson; Ph.D. M.D. Yash Pal Agrawal
 
 
 
Overview
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.

 
Details
  • ISBN-13: 9780786437153
  • ISBN-10: 0786437154
  • Publisher: McFarland & Company
  • Publish Date: November 2008
  • Page Count: 213
  • Dimensions: 8.8 x 5.9 x 0.7 inches
  • Shipping Weight: 0.75 pounds


Related Categories

Books > Medical > Pharmacology

 
BAM Customer Reviews